Quantifying patient preferences for systemic atopic dermatitis treatments using a discrete-choice experiment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Quantifying patient preferences for systemic atopic dermatitis treatments using a discrete-choice experiment

Published:2020-11-02 Issue: Volume: Page:1-10
ISSN:0954-6634
Container-title:Journal of Dermatological Treatment
language:en
Short-container-title:Journal of Dermatological Treatment

Author:

Boeri Marco¹,Sutphin Jessie²,Hauber Brett²³,Cappelleri Joseph C.⁴,Romero William⁵,Di Bonaventura Marco⁶

Affiliation:

1. RTI Health Solutions, Belfast, UK

2. RTI Health Solutions, Research Triangle Park, NC, USA

3. Comparative Health Outcomes, Policy and Economics (CHOICE) Institute, University of Washington School of Pharmacy, Seattle, WA, USA

4. Pfizer Inc, Groton, CT, USA

5. Pfizer Ltd, Surrey, UK

6. Pfizer Inc, New York, NY, USA

Funder

Pfizer Inc.

Publisher

Informa UK Limited

Subject

Dermatology

Link

https://www.tandfonline.com/doi/pdf/10.1080/09546634.2020.1832185

Reference36 articles.

1. Atopic dermatitis yardstick: Practical recommendations for an evolving therapeutic landscape

2. Exploring content and psychometric validity of newly developed assessment tools for itch and skin pain in atopic dermatitis

3. Pain Is a Common and Burdensome Symptom of Atopic Dermatitis in United States Adults

4. Nonlesional atopic dermatitis skin is characterized by broad terminal differentiation defects and variable immune abnormalities

5. Burden of skin pain in atopic dermatitis

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quand mettre en route un traitement systémique dans la dermatite atopique ?;Annales de Dermatologie et de Vénéréologie - FMC;2024-06

2. Treatment Preference Research in Atopic Dermatitis: A Systematic Review of Quantitative Studies;The Patient - Patient-Centered Outcomes Research;2024-05-09

3. Patient preferences for treatment attributes in moderate-to-severe atopic dermatitis: a discrete choice experiment;Journal of Dermatological Treatment;2024-05-05

4. Effects of abrocitinib on pruritus and eczema symptoms and tolerance in patients with moderate‑to‑severe atopic dermatitis in randomized, double‑blind and placebo‑controlled trials: A systematic review and a meta‑analysis;Biomedical Reports;2024-03-29

5. Patient Preferences in the Treatment of Moderate-to-severe Atopic Dermatitis;Acta Dermato-Venereologica;2024-02-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3